Year archive

H. Lundbeck A — 2026 filings

All 17 regulatory filings released by H. Lundbeck A (HLUN) in 2026, sourced directly from the official regulator.

17 Filings

2026 Period

2026 filings (17)

Filing	Released	Lang
Lundbeck raises financial guidance for 2026 Regulatory Filings	2026-05-12	English
Lundbeck raises financial guidance for 2026 Regulatory Filings	2026-05-12	English
Lundbeck announces last patient randomized ahead-of-schedule in Phase 3 MASCOT trial Regulatory Filings	2026-03-09	English
Lundbeck announces last patient randomized ahead-of-schedule in Phase 3 MASCOT trial Regulatory Filings	2026-03-09	English
Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties Director's Dealing	2026-02-18	English
Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties Director's Dealing	2026-02-18	English
Lundbeck announces positive phase IIb top-line results with bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention Regulatory Filings	2026-02-12	English
Lundbeck announces positive phase IIb top-line results with bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention Regulatory Filings	2026-02-12	English
Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties Director's Dealing	2026-02-06	English
Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties Director's Dealing	2026-02-06	English
Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties Director's Dealing	2026-02-04	English
Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties Director's Dealing	2026-02-04	English
Lundbeck Annual Report 2025 Report Publication Announcement	2026-02-04	English
Lundbeck Annual Report 2025 Annual Report (ESEF) FY 2025	2026-02-04	English
Lundbeck Annual Report 2025 Annual Report FY 2025	2026-02-04	English
Record 2025 performance with revenue up 13% CER and adjusted EBITDA up 24% CER positions Lundbeck for continued growth in 2026 Earnings Release FY 2025	2026-02-04	English
Record 2025 performance with revenue up 13% CER and adjusted EBITDA up 24% CER positions Lundbeck for continued growth in 2026 Earnings Release FY 2025	2026-02-04	English

Filings by year

2026 17 filings
2025 28 filings
2024 22 filings
2023 28 filings
2022 27 filings
2021 20 filings
2020 14 filings
2019 55 filings
2018 63 filings
2017 105 filings
2016 122 filings
2015 31 filings
2014 43 filings
2013 56 filings
2012 66 filings
2011 73 filings
2010 74 filings
2009 42 filings
2008 29 filings
2007 32 filings